Vertex Pharmaceuticals Stock Forecast - Price Action Indicator

VRTX Stock  USD 397.36  0.81  0.20%   
Vertex Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Vertex Pharmaceuticals stock prices and determine the direction of Vertex Pharmaceuticals's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Vertex Pharmaceuticals' historical fundamentals, such as revenue growth or operating cash flow patterns. Although Vertex Pharmaceuticals' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Vertex Pharmaceuticals' systematic risk associated with finding meaningful patterns of Vertex Pharmaceuticals fundamentals over time.
Check out Historical Fundamental Analysis of Vertex Pharmaceuticals to cross-verify your projections.
For more information on how to buy Vertex Stock please use our How to Invest in Vertex Pharmaceuticals guide.
  
At this time, Vertex Pharmaceuticals' Payables Turnover is fairly stable compared to the past year. Receivables Turnover is likely to rise to 9.08 in 2024, whereas Inventory Turnover is likely to drop 1.62 in 2024. . Net Income Applicable To Common Shares is likely to rise to about 4 B in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 153.1 M in 2024.

Open Interest Against 2024-04-19 Vertex Option Contracts

Although open interest is a measure utilized in the options markets, it could be used to forecast Vertex Pharmaceuticals' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Vertex Pharmaceuticals' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Vertex Pharmaceuticals stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Vertex Pharmaceuticals' open interest, investors have to compare it to Vertex Pharmaceuticals' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Vertex Pharmaceuticals is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Vertex. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Vertex Pharmaceuticals has current Price Action Indicator of (1.82).
Most investors in Vertex Pharmaceuticals cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Vertex Pharmaceuticals' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Vertex Pharmaceuticals' price structures and extracts relationships that further increase the generated results' accuracy.
Price Action indicator evaluates an asset for a given trading period using the following formula: ((close - open) + (close - high) + (close - low)) / 2. This indicator is consistent with the interpretation of Japanese candlestick patterns.
Check Vertex Pharmaceuticals VolatilityBacktest Vertex PharmaceuticalsInformation Ratio  

Vertex Pharmaceuticals Trading Date Momentum

On April 15 2024 Vertex Pharmaceuticals was traded for  397.36  at the closing time. The top price for the day was 402.49  and the lowest listed price was  396.69 . The trading volume for the day was 1.4 M. The trading history from April 15, 2024 did not result in any price rise and fall. The trading price change against the current closing price is 0.66% .
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
Compare Vertex Pharmaceuticals to competition

Other Forecasting Options for Vertex Pharmaceuticals

For every potential investor in Vertex, whether a beginner or expert, Vertex Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Vertex Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Vertex. Basic forecasting techniques help filter out the noise by identifying Vertex Pharmaceuticals' price trends.

View Vertex Pharmaceuticals Related Equities

 Risk & Return  Correlation

Vertex Pharmaceuticals Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Vertex Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Vertex Pharmaceuticals' current price.

Vertex Pharmaceuticals Market Strength Events

Market strength indicators help investors to evaluate how Vertex Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Vertex Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Vertex Pharmaceuticals stock market strength indicators, traders can identify Vertex Pharmaceuticals entry and exit signals to maximize returns.

Vertex Pharmaceuticals Risk Indicators

The analysis of Vertex Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Vertex Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting vertex stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Vertex Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Vertex Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vertex Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Vertex Pharmaceuticals Stock:
Check out Historical Fundamental Analysis of Vertex Pharmaceuticals to cross-verify your projections.
For more information on how to buy Vertex Stock please use our How to Invest in Vertex Pharmaceuticals guide.
You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Complementary Tools for Vertex Stock analysis

When running Vertex Pharmaceuticals' price analysis, check to measure Vertex Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vertex Pharmaceuticals is operating at the current time. Most of Vertex Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Vertex Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vertex Pharmaceuticals' price. Additionally, you may evaluate how the addition of Vertex Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Transaction History
View history of all your transactions and understand their impact on performance
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Bonds Directory
Find actively traded corporate debentures issued by US companies
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Is Vertex Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vertex Pharmaceuticals. If investors know Vertex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vertex Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.181
Earnings Share
13.88
Revenue Per Share
38.297
Quarterly Revenue Growth
0.093
Return On Assets
0.1317
The market value of Vertex Pharmaceuticals is measured differently than its book value, which is the value of Vertex that is recorded on the company's balance sheet. Investors also form their own opinion of Vertex Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Vertex Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vertex Pharmaceuticals' market value can be influenced by many factors that don't directly affect Vertex Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vertex Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Vertex Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vertex Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.